Editorial board

Kevin Davies, MD Mary Ann Liebert, Inc., New Rochelle, NY, USA

Pete Gagnon Chief Scientific Officer BIA Separations
David Giljohann, PhD AuraSense, Evanston, IL, USA
Uwe Gottschalk, PhD Chief Scientific Officer Lonza
Harry E. Gruber, MD CEO, Tocagen
James Inglese, PhD Principal Investigator, National Center for Advancing Translational Sciences
Guenter Jagschies Senior Director, GE Healthcare Life Sciences
Cigall Kadoch, PhD Assistant Professor, Dept. of Pediatric Oncology, Dana Farber Cancer Institute and Harvard Medical School
Anis H. Khimani, PhD Head of Strategy and Marketing Research, Reagent Solutions PerkinElmer
Ivan Liachko, PhD CEO, Phase Genomics
Miodrag MIcic, ScD, PhD Professor and Department Chairman, Cerritos College
Eric Schadt, PhD Founder and CEO, Sema4
Zhiwei Song, PhD Scientist, Bioprocessing Technology Institute, Singapore
Ali Torkamani, PhD Director of Genomics and Genome Informatics, Scripps Research Translational Institute
Fyodor, D. Urnov, PhD Deputy Director, Altius Institute
Bin Wang, PhD Professor Principal Investigator, Shanghai University Medical College